Cryo Cell International Gross Profit Growth & History (CCEL)
Cryo Cell International's gross profit was $24.2M for fiscal 2025.
View full Cryo Cell International company overviewCryo Cell International annual gross profit history
| Fiscal year | Period ended | Gross profit | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-11-30 | $24.2M | $151,319 | +0.63% |
| 2024 | 2024-11-30 | $24.0M | $1.1M | +4.73% |
| 2023 | 2023-11-30 | $23.0M | $1.4M | +6.54% |
| 2022 | 2022-11-30 | $21.5M | $1.6M | +8.29% |
| 2021 | 2021-11-30 | $19.9M | −$1.6M | −7.42% |
| 2020 | 2020-11-30 | $21.5M | −$290,245 | −1.33% |
| 2019 | 2019-11-30 | $21.8M | $1.1M | +5.33% |
| 2018 | 2018-11-30 | $20.7M | $2.0M | +10.82% |
| 2017 | 2017-11-30 | $18.7M | $1.3M | +7.53% |
| 2016 | 2016-11-30 | $17.4M | $1.9M | +12.24% |
| 2015 | 2015-11-30 | $15.5M | $966,061 | +6.67% |
| 2014 | 2014-11-30 | $14.5M | $822,162 | +6.01% |
| 2013 | 2013-11-30 | $13.7M | $590,902 | +4.52% |
| 2012 | 2012-11-30 | $13.1M | −$437,385 | −3.24% |
| 2011 | 2011-11-30 | $13.5M | $261,087 | +1.97% |
| 2010 | 2010-11-30 | $13.3M | — | — |
Cryo Cell International quarterly gross profit
| Fiscal quarter | Period ended | Gross profit | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-05-31 | $6.1M | $27,146 | +0.45% |
| Q1 2026 | 2026-02-28 | $6.0M | $42,337 | +0.71% |
| Q4 2025 | 2025-11-30 | $6.1M | −$184,496 | −2.93% |
| Q3 2025 | 2025-08-31 | $6.0M | $83,144 | +1.40% |
| Q2 2025 | 2025-05-31 | $6.1M | $54,243 | +0.90% |
| Q1 2025 | 2025-02-28 | $6.0M | $198,428 | +3.43% |
| Q4 2024 | 2024-11-30 | $6.3M | $440,571 | +7.53% |
| Q3 2024 | 2024-08-31 | $5.9M | $227,181 | +3.98% |
| Q2 2024 | 2024-05-31 | $6.0M | $388,557 | +6.90% |
| Q1 2024 | 2024-02-29 | $5.8M | $28,813 | +0.50% |
| Q4 2023 | 2023-11-30 | $5.9M | $227,808 | +4.05% |
| Q3 2023 | 2023-08-31 | $5.7M | $381,484 | +7.15% |
| Q2 2023 | 2023-05-31 | $5.6M | $197,827 | +3.64% |
| Q1 2023 | 2023-02-28 | $5.8M | $601,722 | +11.67% |
| Q4 2022 | 2022-11-30 | $5.6M | $605,673 | +12.07% |
| Q3 2022 | 2022-08-31 | $5.3M | $287,490 | +5.70% |
| Q2 2022 | 2022-05-31 | $5.4M | $449,153 | +9.01% |
| Q1 2022 | 2022-02-28 | $5.2M | $306,909 | +6.33% |
| Q4 2021 | 2021-11-30 | $5.0M | −$207,678 | −3.97% |
| Q3 2021 | 2021-08-31 | $5.0M | −$709,320 | −12.33% |
| Q2 2021 | 2021-05-31 | $5.0M | −$408,777 | −7.58% |
| Q1 2021 | 2021-02-28 | $4.8M | −$269,210 | −5.26% |
| Q4 2020 | 2020-11-30 | $5.2M | −$390,706 | −6.95% |
| Q3 2020 | 2020-08-31 | $5.8M | $119,976 | +2.13% |
| Q2 2020 | 2020-05-31 | $5.4M | −$108,260 | −1.97% |
| Q1 2020 | 2020-02-29 | $5.1M | $88,745 | +1.76% |
| Q4 2019 | 2019-11-30 | $5.6M | −$300,959 | −5.08% |
| Q3 2019 | 2019-08-31 | $5.6M | $249,016 | +4.62% |
| Q2 2019 | 2019-05-31 | $5.5M | $751,236 | +15.82% |
| Q1 2019 | 2019-02-28 | $5.0M | $402,275 | +8.69% |
| Q4 2018 | 2018-11-30 | $5.9M | $1.1M | +22.39% |
| Q3 2018 | 2018-08-31 | $5.4M | $466,576 | +9.49% |
| Q2 2018 | 2018-05-31 | $4.7M | $103,540 | +2.23% |
| Q1 2018 | 2018-02-28 | $4.6M | $366,083 | +8.59% |
| Q4 2017 | 2017-11-30 | $4.8M | $409,433 | +9.25% |
| Q3 2017 | 2017-08-31 | $4.9M | $137,759 | +2.88% |
| Q2 2017 | 2017-05-31 | $4.6M | $302,829 | +6.97% |
| Q1 2017 | 2017-02-28 | $4.3M | $456,620 | +12.00% |
| Q4 2016 | 2016-11-30 | $4.4M | $100,604 | +2.33% |
| Q3 2016 | 2016-08-31 | $4.8M | $852,110 | +21.69% |
| Q2 2016 | 2016-05-31 | $4.3M | $705,454 | +19.40% |
| Q1 2016 | 2016-02-29 | $3.8M | $234,513 | +6.57% |
| Q4 2015 | 2015-11-30 | $4.3M | $659,036 | +17.97% |
| Q3 2015 | 2015-08-31 | $3.9M | $490,391 | +14.26% |
| Q2 2015 | 2015-05-31 | $3.6M | $233,361 | +6.86% |
| Q1 2015 | 2015-02-28 | $3.6M | −$416,727 | −10.45% |
| Q4 2014 | 2014-11-30 | $3.7M | $267,879 | +7.88% |
| Q3 2014 | 2014-08-31 | $3.4M | −$31,166 | −0.90% |
| Q2 2014 | 2014-05-31 | $3.4M | −$80,398 | −2.31% |
| Q1 2014 | 2014-02-28 | $4.0M | $665,847 | +20.05% |
| Q4 2013 | 2013-11-30 | $3.4M | −$98,965 | −2.83% |
| Q3 2013 | 2013-08-31 | $3.5M | $253,389 | +7.88% |
| Q2 2013 | 2013-05-31 | $3.5M | $267,890 | +8.33% |
| Q1 2013 | 2013-02-28 | $3.3M | $168,588 | +5.35% |
| Q4 2012 | 2012-11-30 | $3.5M | $1,556 | +0.04% |
| Q3 2012 | 2012-08-31 | $3.2M | $2,277 | +0.07% |
| Q2 2012 | 2012-05-31 | $3.2M | −$281,619 | −8.05% |
| Q1 2012 | 2012-02-29 | $3.2M | −$159,599 | −4.82% |
| Q4 2011 | 2011-11-30 | $3.5M | — | — |
| Q3 2011 | 2011-08-31 | $3.2M | −$265,587 | −7.63% |
| Q2 2011 | 2011-05-31 | $3.5M | — | — |
| Q1 2011 | 2011-02-28 | $3.3M | — | — |
| Q3 2010 | 2010-08-31 | $3.5M | — | — |
Cryo Cell International gross profit trends
Over the last five fiscal years, Cryo Cell International's gross profit increased from $21.5M to $24.2M, a change of $2.7M. The latest reported quarter, Q2 2026, shows $6.1M.
What gross profit means
Gross profit is the amount of revenue remaining after the direct costs of producing and delivering a company’s goods or services. It helps show the dollars available to cover operating expenses before operating income, interest, and taxes.
SEC-reported and calculated gross profit
TickerStat uses gross profit reported in company SEC filings when available. Otherwise, it calculates gross profit as SEC-reported revenue minus aligned cost of revenue for the same fiscal period. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Cryo Cell International source filings ↗